What technical signals does OptimizeRx (OPRX) have?

OptimizeRx current technical signals: MA alignment (score 0.83).

Is OptimizeRx a cup-and-handle pattern?

No. OptimizeRx has no valid Cup signal right now.

What published figures are available for OptimizeRx?

Market cap: $162.55M. Trailing 12 months PER: 35.6×. Latest quarter PBR: 1.25×. Dividend yield: 0.00%.

← Signal Board

OptimizeRx stock price

옵티마이즈RXNASDAQ:OPRX · Nasdaq · Software · sector #12

$8.72+1.75%

2026-10-05 close

Today's signals · MA aligned

Signal details →

OptimizeRx last closed at $8.72 (+1.75%) on 2026-10-05. Signals today: MA aligned. Listed on Nasdaq. Trailing 12 months PER is 35.6×. Its overall grade ranks 188 of 367 stocks in Software.

About this company

OptimizeRx last closed at $8.72 (+1.75%) on 2026-10-05. Signals today: MA aligned. Listed on Nasdaq.

Details →

Reported results

Details →

Position in sector

Software · Overall B- · 188/367

Valuation grade B+

Details →

Related stocks

Eli LillyCustomer
제약사 대상 디지털 마케팅·처방 촉진 솔루션의 주요 고객군
PfizerCustomer
제약사 대상 환자·의사 타깃 마케팅 솔루션의 주요 고객군
MerckCustomer
제약사 대상 처방 전환·브랜드 캠페인 집행의 핵심 고객군

Details →

About OptimizeRx

What technical signals does OptimizeRx (OPRX) have?: OptimizeRx current technical signals: MA alignment (score 0.83).
Is OptimizeRx a cup-and-handle pattern?: No. OptimizeRx has no valid Cup signal right now.
What published figures are available for OptimizeRx?: Market cap: $162.55M. Trailing 12 months PER: 35.6×. Latest quarter PBR: 1.25×. Dividend yield: 0.00%.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗